Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clevenger, C. V.
Right arrow Articles by Gewirtz, , A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clevenger, C. V.
Right arrow Articles by Gewirtz, , A. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 22, Issue of June 2, pp. 13246-13253, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Vav Is Necessary for Prolactin-stimulated Proliferation and Is Translocated into the Nucleus of a T-cell Line

Charles V. Clevenger , Winnie Ngo , Deborah L. Sokol , Selina M. Luger , , Alan M. Gewirtz

Stimulation of the prolactin receptor (PRLr) with ligand activates multiple kinase cascades. The proximal mediators involved in the activation of the PRL-activated Raf-1 cascade in T-cells, however, remain poorly characterized. The role of one proximal signaling protein, namely p95, during PRLr signal transduction was examined in the Nb2 T-cell line. The novel results obtained here indicate that Vav is transiently associated with the PRLr and is necessary for PRL-stimulated proliferation. During PRL stimulation, a rapid and dramatic increase in guanine nucleotide exchange factor (GEF) activity was found to be associated with Vav immunoprecipitates. Concomitantly, an increase in Vav phosphorylation on serine-threonine residues was observed. The Vav-associated GEF activation could be inhibited by staurosporine and calphostin, but not herbimycin, suggesting a modulatory role for phosphorylation at serine-threonine residues. Treatment of Nb2 cells with antisense Vav oligonucleotide ablated Vav expression and blocked PRL-driven proliferation, but failed to inhibit PRL-induced GEF activation within Nb2 lysates. These data indicate that GEF activity may not be intrinsic to Vav as has been previously suggested, but either resides in or is complemented by an associated GEF. Subsequent to the transient activation of associated GEF activity, Vav was found to translocate into the Nb2 cell nucleus. Thus, Vav may utilize two independent mechanisms in T-cells, namely the activation of an associated GEF and direct nuclear internalization, to mediate PRLr signaling.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ReproductionHome page
A. Bachelot and N. Binart
Reproductive role of prolactin
Reproduction, February 1, 2007; 133(2): 361 - 369.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. M. Stephenson, A. V. Miletic, T. Kloeppel, S. Kusin, and W. Swat
Vav Proteins Regulate the Plasma Cell Program and Secretory Ig Production
J. Immunol., December 15, 2006; 177(12): 8620 - 8625.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. L. Gadd and C. V. Clevenger
Ligand-Independent Dimerization of the Human Prolactin Receptor Isoforms: Functional Implications
Mol. Endocrinol., November 1, 2006; 20(11): 2734 - 2746.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. B. Opalinska, B. Machalinski, J. Ratajczak, M. Z. Ratajczak, and A. M. Gewirtz
Multigene Targeting with Antisense Oligodeoxynucleotides: An Exploratory Study Using Primary Human Leukemia Cells
Clin. Cancer Res., July 1, 2005; 11(13): 4948 - 4954.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. L. Miller, J. E. DeMaria, D. O. Freier, A. M. Riegel, and C. V. Clevenger
Novel Association of Vav2 and Nek3 Modulates Signaling through the Human Prolactin Receptor
Mol. Endocrinol., April 1, 2005; 19(4): 939 - 949.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Katzav
Vav1: an oncogene that regulates specific transcriptional activation of T cells
Blood, April 1, 2004; 103(7): 2443 - 2451.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. J. Acosta, R. M. Munoz, L. Gonzalez, A. Subtil-Rodriguez, M. A. Dominguez-Caceres, J. M. Garcia-Martinez, A. Calcabrini, I. Lazaro-Trueba, and J. Martin-Perez
Src Mediates Prolactin-Dependent Proliferation of T47D and MCF7 Cells via the Activation of Focal Adhesion Kinase/Erk1/2 and Phosphatidylinositol 3-Kinase Pathways
Mol. Endocrinol., November 1, 2003; 17(11): 2268 - 2282.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Qi, A. Fournier, J. Grenier, C. Fillion, Y. Labrie, and C. Labrie
Isolation of the Novel Human Guanine Nucleotide Exchange Factor Src Homology 3 Domain-Containing Guanine Nucleotide Exchange Factor (SGEF) and of C-Terminal SGEF, an N-Terminally Truncated Form of SGEF, the Expression of Which Is Regulated by Androgen in Prostate Cancer Cells
Endocrinology, May 1, 2003; 144(5): 1742 - 1752.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. C. Lanning, R. Ruiz-Velasco, and C. L. Williams
Novel Mechanism of the Co-regulation of Nuclear Transport of SmgGDS and Rac1
J. Biol. Chem., March 28, 2003; 278(14): 12495 - 12506.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler
The Role of Prolactin in Mammary Carcinoma
Endocr. Rev., February 1, 2003; 24(1): 1 - 27.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Rycyzyn and C. V. Clevenger
The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer
PNAS, May 14, 2002; 99(10): 6790 - 6795.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Luger, S. G. O'Brien, J. Ratajczak, M. Z. Ratajczak, R. Mick, E. A. Stadtmauer, P. C. Nowell, J. M. Goldman, and A. M. Gewirtz
Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot study
Blood, February 15, 2002; 99(4): 1150 - 1158.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C V Clevenger and J B Kline
Prolactin receptor signal transduction
Lupus, October 1, 2001; 10(10): 706 - 718.
[Abstract] [PDF]


Home page
EndocrinologyHome page
D. E. Fleenor and M. Freemark
Prolactin Induction of Insulin Gene Transcription: Roles of Glucose and Signal Transducer and Activator of Transcription 5
Endocrinology, July 1, 2001; 142(7): 2805 - 2810.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. B. Kline, D. J. Moore, and C. V. Clevenger
Activation and Association of the Tec Tyrosine Kinase with the Human Prolactin Receptor: Mapping of a Tec/Vav1-Receptor Binding Site
Mol. Endocrinol., May 1, 2001; 15(5): 832 - 841.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
V. Bertagnolo, M. Marchisio, F. Brugnoli, A. Bavelloni, L. Boccafogli, M. L. Colamussi, and S. Capitani
Requirement of Tyrosine-phosphorylated Vav for Morphological Differentiation of All-trans-Retinoic Acid-treated HL-60 Cells
Cell Growth Differ., April 1, 2001; 12(4): 193 - 200.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
M.-P. Gulli and M. Peter
Temporal and spatial regulation of Rho-type guanine-nucleotide exchange factors: the yeast perspective
Genes & Dev., February 15, 2001; 15(4): 365 - 379.
[Full Text]


Home page
Mol. Endocrinol.Home page
M. A. Rycyzyn, S. C. Reilly, K. O’Malley, and C. V. Clevenger
Role of Cyclophilin B in Prolactin Signal Transduction and Nuclear Retrotranslocation
Mol. Endocrinol., August 1, 2000; 14(8): 1175 - 1186.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
I. Olazabal, J. Muñoz, S. Ogueta, E. Obregón, and J. P. García-Ruiz
Prolactin (PRL)-PRL Receptor System Increases Cell Proliferation Involving JNK (c-Jun Amino Terminal Kinase) and AP-1 Activation: Inhibition by Glucocorticoids
Mol. Endocrinol., April 1, 2000; 14(4): 564 - 575.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
X. R. Bustelo
Regulatory and Signaling Properties of the Vav Family
Mol. Cell. Biol., March 1, 2000; 20(5): 1461 - 1477.
[Full Text]


Home page
Mol. Endocrinol.Home page
K. M. McAveney, M. L. Book, P. Ling, J. Chebath, and L.-y. Yu-Lee
Association of 2',5'-Oligoadenylate Synthetase with the Prolactin (PRL) Receptor: Alteration in PRL-Inducible Stat1 (Signal Transducer and Activator of Transcription 1) Signaling to the IRF-1 (Interferon-Regulatory Factor 1) Promoter
Mol. Endocrinol., February 1, 2000; 14(2): 295 - 306.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
K. E. Borg, M. Zhang, D. Hegge, R. L. Stephen, D. J. Buckley, N. S. Magnuson, and A. R. Buckley
Prolactin Regulation of pim-1 Expression: Positive and Negative Promoter Elements
Endocrinology, December 1, 1999; 140(12): 5659 - 5668.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
P. Morales, M. V. Carretero, H. Geronimo, S. G. Copín, M. L. Gaspar, M. A. R. Marcos, and J. Martín-Pérez
Influence of Prolactin on the Differentiation of Mouse B-Lymphoid Precursors
Cell Growth Differ., August 1, 1999; 10(8): 583 - 590.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
K. V. Salojin, J. Zhang, and T. L. Delovitch
TCR and CD28 Are Coupled Via ZAP-70 to the Activation of the Vav/Rac-1-/PAK-1/p38 MAPK Signaling Pathway
J. Immunol., July 15, 1999; 163(2): 844 - 853.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Germani, F. Romero, M. Houlard, J. Camonis, S. Gisselbrecht, S. Fischer, and N. Varin-Blank
hSiah2 Is a New Vav Binding Protein Which Inhibits Vav-Mediated Signaling Pathways
Mol. Cell. Biol., May 1, 1999; 19(5): 3798 - 3807.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. L. Sokol, X. Zhang, P. Lu, and A. M. Gewirtz
Real time detection of DNA·RNA hybridization in living cells
PNAS, September 29, 1998; 95(20): 11538 - 11543.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
Endocr. Rev., June 1, 1998; 19(3): 225 - 268.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
F. Romero, A. Germani, E. Puvion, J. Camonis, N. Varin-Blank, S. Gisselbrecht, and S. Fischer
Vav Binding to Heterogeneous Nuclear Ribonucleoprotein (hnRNP) C. EVIDENCE FOR Vav-hnRNP INTERACTIONS IN AN RNA-DEPENDENT MANNER
J. Biol. Chem., March 6, 1998; 273(10): 5923 - 5931.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W.-P. Chang, Y. Ye, and C. V. Clevenger
Stoichiometric Structure-Function Analysis of the Prolactin Receptor Signaling Domain by Receptor Chimeras
Mol. Cell. Biol., February 1, 1998; 18(2): 896 - 905.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Shigematsu, H. Iwasaki, T. Otsuka, Y. Ohno, F. Arima, and Y. Niho
Role of the vav Proto-oncogene Product (Vav) in Erythropoietin-mediated Cell Proliferation and Phosphatidylinositol 3-Kinase Activity
J. Biol. Chem., May 30, 1997; 272(22): 14334 - 14340.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. V. Clevenger, K. Thickman, W. Ngo, W.-P. Chang, S. Takayama, and J. C. Reed
Role of Bag-1 in the Survival and Proliferation of the Cytokine-Dependent Lymphocyte Lines, Ba/F3 and Nb2
Mol. Endocrinol., May 1, 1997; 11(5): 608 - 618.
[Abstract] [Full Text]


Home page
BloodHome page
Y. Miyakawa, A. Oda, B. J. Druker, K. Ozaki, M. Handa, H. Ohashi, and Y. Ikeda
Thrombopoietin and Thrombin Induce Tyrosine Phosphorylation of Vav in Human Blood Platelets
Blood, April 15, 1997; 89(8): 2789 - 2798.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Song, J. Gomez, L. F. Stancato, and J. Rivera
Association of a p95 Vav-containing Signaling Complex with the Fcepsilon RI gamma Chain in the RBL-2H3 Mast Cell Line. EVIDENCE FOR A CONSTITUTIVE IN VIVO ASSOCIATION OF Vav WITH Grb2, Raf-1, AND ERK2 IN AN ACTIVE COMPLEX
J. Biol. Chem., October 25, 1996; 271(43): 26962 - 26970.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. R. Duan, D. I.H. Linzer, and G. Gibori
Cloning and Characterization of an Ovarian-specific Protein That Associates with the Short Form of the Prolactin Receptor
J. Biol. Chem., June 28, 1996; 271(26): 15602 - 15607.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
N Bonnefoy-Berard, A Munshi, I Yron, S Wu, T. Collins, M Deckert, T Shalom- Barak, L Giampa, E Herbert, J Hernandez, et al.
Vav: function and regulation in hematopoietic cell signaling
Stem Cells, May 1, 1996; 14(3): 250 - 268.
[Abstract]


Home page
JEMHome page
M. Houlard, R. Arudchandran, F. Regnier-Ricard, A. Germani, S. Gisselbrecht, U. Blank, J. Rivera, and N. Varin-Blank
Vav1 Is a Component of Transcriptionally Active Complexes
J. Exp. Med., May 6, 2002; 195(9): 1115 - 1127.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement